Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relpax for Prevention of Menstrual Migraine
NCT00259649Phase 4Completed
- Sponsor
- University of Pittsburgh
- Start
- Aug 2004
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of eletriptan in menstrual migraine, sponsored by University of Pittsburgh. Primary endpoint: Change in Mean Headache Index Score Among Patients at 3 months. Started Aug 2004; status: completed.
02
Drugs
eletriptan
03
Conditions
menstrual migraine
Beyond the preview
Go deeper on NCT00259649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00259649.